Wernicke's encephalopathy in a child with Down syndrome, undergoing treatment for acute lymphoblastic leukemia
dc.contributor.author | Yıldırım A.T. | |
dc.contributor.author | Bilgili G. | |
dc.contributor.author | Akman B. | |
dc.contributor.author | Ovalı G.Y. | |
dc.contributor.author | Özgüven A.A. | |
dc.contributor.author | Gülen H. | |
dc.date.accessioned | 2024-07-22T08:11:43Z | |
dc.date.available | 2024-07-22T08:11:43Z | |
dc.date.issued | 2016 | |
dc.description.abstract | [No abstract available] | |
dc.identifier.DOI-ID | 10.1111/ped.12955 | |
dc.identifier.issn | 13288067 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/15763 | |
dc.language.iso | English | |
dc.publisher | Blackwell Publishing | |
dc.subject | asparaginase | |
dc.subject | cyclophosphamide | |
dc.subject | cytarabine | |
dc.subject | daunorubicin | |
dc.subject | mercaptopurine | |
dc.subject | methotrexate | |
dc.subject | prednisolone | |
dc.subject | vincristine | |
dc.subject | vitamin B group | |
dc.subject | acute lymphoblastic leukemia | |
dc.subject | Article | |
dc.subject | brain stem | |
dc.subject | brain third ventricle | |
dc.subject | case report | |
dc.subject | child | |
dc.subject | consciousness disorder | |
dc.subject | consolidation chemotherapy | |
dc.subject | differential diagnosis | |
dc.subject | diffusion weighted imaging | |
dc.subject | Down syndrome | |
dc.subject | drug megadose | |
dc.subject | human | |
dc.subject | hyponatremia | |
dc.subject | inappropriate vasopressin secretion | |
dc.subject | induction chemotherapy | |
dc.subject | leukemia remission | |
dc.subject | male | |
dc.subject | malnutrition | |
dc.subject | medial lemniscus | |
dc.subject | mesencephalon | |
dc.subject | nuclear magnetic resonance imaging | |
dc.subject | priority journal | |
dc.subject | school child | |
dc.subject | total parenteral nutrition | |
dc.subject | vomiting | |
dc.subject | Wernicke encephalopathy | |
dc.title | Wernicke's encephalopathy in a child with Down syndrome, undergoing treatment for acute lymphoblastic leukemia | |
dc.type | Article |